• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于平衡原理的透析间期钠和水摄入量估计:非糖尿病和糖尿病血液透析患者之间的差异

Estimates of interdialytic sodium and water intake based on the balance principle: differences between nondiabetic and diabetic subjects on hemodialysis.

作者信息

Ramdeen G, Tzamaloukas A H, Malhotra D, Leger A, Murata G H

机构信息

Albuquerque Veterans Affairs Medical Center, Department of Medicine, University of New Mexico School of Medicine, 87108, USA.

出版信息

ASAIO J. 1998 Nov-Dec;44(6):812-7. doi: 10.1097/00002480-199811000-00009.

DOI:10.1097/00002480-199811000-00009
PMID:9831090
Abstract

Whether salt or water intake is the primary cause of interdialytic weight gain (deltaW) has important implication for the design of measures to prevent large deltaW. In 17 hemodialysis patients dialyzed against a bath containing 140 mmol/L of sodium, monthly predialysis serum sodium was compared with post dialysis serum sodium. A decrease in serum sodium in the interdialytic period would indicate that primary water consumption accounts for at least part of the deltaW. Interdialytic sodium intake, isotonic fluid gain (deltaW(isotonic)) and net pure water gain (deltaWH2O) were calculated by balance formulae. Serum sodium concentration was corrected in diabetic subjects to the value corresponding to euglycemia (100 mg/dl). Estimated interdialytic sodium intake was compared with the prescribed sodium intake and, in seven subjects, to sodium intake estimated from dietary records. Results for nondiabetic subjects (N = 9): [Na]post 139.3 +/- 1.9 mmol/L, [Na]pre 140.1 +/- 2.1 mmol/L (NS), deltaW 1.15 +/- 0.55 L/24 hr, deltaW(isotonic) 1.33 +/- 0.57 L/24 hr, deltaWH2O -0.20 +/- 0.58 L/24 hr, estimated sodium intake 206 +/- 75 mmol/24 hr, prescribed sodium intake 121 +/- 29 mmol/24 hr (p = 0.028). Results for diabetic subjects (N = 7): [Na]post 140.1 +/- 2.5 mmol/L, [Na]pre 137.7 +/- 3.1 mmol/L (p < 0.01), deltaW 1.26 +/- 0.38 L/24 hr, deltaW(isotonic) 0.59 +/- 0.63 L/24 hr, deltaWH2O 0.66 +/- 0.39 L/24 hr, estimated sodium intake 160 +/- 81 mmol/24 hr, prescribed sodium intake 124 +/- 30 mmol/24 hr (NS), glycosylated hemoglobin 9.7 +/- 2.8% (normal, 4.1-5.7%). In seven subjects, estimates of sodium intake from balance formulae (233 +/- 113 mmol/24 hr) were not different from estimates from dietary records (212 +/- 87 mmol/24 hr). Sodium intake accounted for all the interdialytic weight gain in nondiabetic subjects. In diabetic patients, only approximately half of the interdialytic weight gain was accounted for by sodium intake. The other half was due to pure water gain, probably caused by hyperglycemia.

摘要

盐摄入还是水摄入是透析间期体重增加(ΔW)的主要原因,这对于预防大幅ΔW的措施设计具有重要意义。在17例使用含140 mmol/L钠的透析液进行透析的血液透析患者中,比较了每月透析前血清钠与透析后血清钠。透析间期血清钠降低表明主要的水消耗至少是部分ΔW的原因。通过平衡公式计算透析间期钠摄入量、等渗液增加量(ΔW(等渗))和纯水平衡增加量(ΔWH2O)。糖尿病患者的血清钠浓度校正为对应于血糖正常(100 mg/dl)的值。将估计的透析间期钠摄入量与规定的钠摄入量进行比较,并在7例患者中与根据饮食记录估计的钠摄入量进行比较。非糖尿病患者(N = 9)的结果:透析后[Na] 139.3±1.9 mmol/L,透析前[Na] 140.1±2.1 mmol/L(无显著差异),ΔW 1.15±0.55 L/24小时,ΔW(等渗)1.33±0.57 L/24小时,ΔWH2O -0.20±0.58 L/24小时,估计钠摄入量206±75 mmol/24小时,规定钠摄入量为每日121±29 mmol/24小时(p = 0.028)。糖尿病患者(N = 7)的结果:透析后[Na] 140.1±2.5 mmol/L,透析前[Na] 137.7±3.1 mmol/L(p < 0.01),ΔW 1.26±0.38 L/24小时,ΔW(等渗)0.59±0.63 L/24小时,ΔWH2O 0.66±0.39 L/24小时,估计钠摄入量160±81 mmol/24小时,规定钠摄入量为每日124±30 mmol/24小时(无显著差异),糖化血红蛋白9.7±2.8%(正常,4.1 - 5.7%)。在7例患者中,根据平衡公式估计的钠摄入量(233±113 mmol/24小时)与根据饮食记录估计的钠摄入量(212±87 mmol/24小时)无差异。钠摄入占非糖尿病患者透析间期体重增加的全部原因。在糖尿病患者中,透析间期体重增加只有大约一半是由钠摄入引起的。另一半是由于纯水增加,可能是由高血糖导致的。

相似文献

1
Estimates of interdialytic sodium and water intake based on the balance principle: differences between nondiabetic and diabetic subjects on hemodialysis.基于平衡原理的透析间期钠和水摄入量估计:非糖尿病和糖尿病血液透析患者之间的差异
ASAIO J. 1998 Nov-Dec;44(6):812-7. doi: 10.1097/00002480-199811000-00009.
2
[Assessment of salt intake in hemodialysis].[血液透析中盐摄入量的评估]
Nefrologia. 2001 Jan-Feb;21(1):71-7.
3
Effect of oral sodium bicarbonate supplementation on interdialytic weight gain, plasma sodium concentrations and predialysis blood pressure in hemodialysis patients.口服补充碳酸氢钠对血液透析患者透析间期体重增加、血浆钠浓度及透析前血压的影响。
Blood Purif. 2005;23(5):379-83. doi: 10.1159/000087195. Epub 2005 May 27.
4
Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.钠平衡及钠模式血液透析期间超滤模式组合对维持透析质量及钠和液体平衡的影响。
J Am Soc Nephrol. 2005 Jan;16(1):237-46. doi: 10.1681/ASN.2004070581. Epub 2004 Nov 24.
5
The association of the sodium "setpoint" to interdialytic weight gain and blood pressure in hemodialysis patients.血液透析患者中钠“设定点”与透析间期体重增加及血压的关联。
Int J Artif Organs. 2007 Nov;30(11):971-9. doi: 10.1177/039139880703001105.
6
Reducing sodium intake in hemodialysis patients.降低血液透析患者的钠摄入量。
Semin Dial. 2009 May-Jun;22(3):260-3. doi: 10.1111/j.1525-139X.2009.00570.x.
7
Results of Salt Intake Restriction Monitored with the New Sodium Control Biosensor.新钠离子控制生物传感器监测下的盐摄入量限制结果。
Am J Nephrol. 2023;54(7-8):291-298. doi: 10.1159/000531521. Epub 2023 Jun 13.
8
Role of dialysis sodium gradient on intradialytic hypertension: an observational study.透析钠梯度对透析中高血压的作用:一项观察性研究。
Am J Nephrol. 2013;38(5):413-9. doi: 10.1159/000355974. Epub 2013 Nov 5.
9
Interdialytic weight gain correlates with glycosylated hemoglobin in diabetic hemodialysis patients.糖尿病血液透析患者透析间期体重增加与糖化血红蛋白相关。
Am J Kidney Dis. 1994 May;23(5):686-91. doi: 10.1016/s0272-6386(12)70279-2.
10
Individualized dialysate sodium prescriptions using sodium gradients for high-risk hemodialysis patients lowered interdialytic weight gain and achieved target weights.对于高危血液透析患者,使用钠梯度的个体化透析液钠处方可降低透析间期体重增加,并达到目标体重。
Hemodial Int. 2020 Jul;24(3):406-413. doi: 10.1111/hdi.12830. Epub 2020 Mar 5.

引用本文的文献

1
Effect of long-term serum sodium levels on the prognosis of patients on maintenance hemodialysis.长期血清钠水平对维持性血液透析患者预后的影响。
Ren Fail. 2024 Dec;46(1):2314629. doi: 10.1080/0886022X.2024.2314629. Epub 2024 Feb 18.
2
Association between home meal preparers and salt intake in haemodialysis patients: a cross-sectional study.血液透析患者中家庭膳食制作者与盐摄入量的关系:一项横断面研究。
BMJ Open. 2024 Feb 7;14(2):e075214. doi: 10.1136/bmjopen-2023-075214.
3
Home-delivered meals as an adjuvant to improve volume overload and clinical outcomes in hemodialysis.
居家送餐作为改善血液透析中容量超负荷和临床结局的辅助手段。
Clin Kidney J. 2022 Apr 19;15(10):1829-1837. doi: 10.1093/ckj/sfac102. eCollection 2022 Oct.
4
Nutrition and quality of life in chronic kidney disease patients: a practical approach for salt restriction.慢性肾脏病患者的营养与生活质量:限盐实用方法
Kidney Res Clin Pract. 2022 Nov;41(6):657-669. doi: 10.23876/j.krcp.21.203. Epub 2022 Jan 21.
5
Dysnatremias in Chronic Kidney Disease: Pathophysiology, Manifestations, and Treatment.慢性肾脏病中的钠代谢紊乱:病理生理学、表现及治疗
Front Med (Lausanne). 2021 Dec 6;8:769287. doi: 10.3389/fmed.2021.769287. eCollection 2021.
6
Association between salt intake and long-term mortality in hemodialysis patients: A retrospective cohort study.盐摄入量与血液透析患者长期死亡率的关联:一项回顾性队列研究。
PLoS One. 2021 Dec 16;16(12):e0260671. doi: 10.1371/journal.pone.0260671. eCollection 2021.
7
Thirst in patients on chronic hemodialysis: What do we know so far?慢性血液透析患者的口渴问题:目前我们了解多少?
Int Urol Nephrol. 2020 Apr;52(4):697-711. doi: 10.1007/s11255-020-02401-5. Epub 2020 Feb 25.
8
Dialysis-associated hyperglycemia: manifestations and treatment.透析相关性高血糖症:临床表现与治疗。
Int Urol Nephrol. 2020 Mar;52(3):505-517. doi: 10.1007/s11255-019-02373-1. Epub 2020 Jan 18.
9
Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications.高血糖危象时的血清钠浓度与张力:主要影响因素及治疗意义
J Am Heart Assoc. 2019 Oct;8(19):e011786. doi: 10.1161/JAHA.118.011786. Epub 2019 Sep 24.
10
Feasibility of Assessing Sodium-Associated Body Fluid Composition in End-Stage Renal Disease.评估终末期肾病患者钠相关体液成分的可行性。
Nurs Res. 2019 May/Jun;68(3):246-252. doi: 10.1097/NNR.0000000000000320.